Vivek Kotecha


Vivek Kotecha

Vivek Kotecha

Vivek is CHPI's Research Manager. He has previously worked as a manager in Monitor and NHS Improvement analysing and reporting on the operational and financial performance of the provider sector. Prior to that he worked as a management consultant at Deloitte for 4 years. Vivek holds a BSc Economics (Hons) from the LSE, a MSc Economics, and is a chartered accountant.See all posts by Vivek Kotecha
Who decides the price and availability of NHS medicines? Outrage and dismay over the prices charged for new medicines are becoming an increasingly regular occurrence in England. Most recently it was over a life-extending drug for cystic fibrosis, Orkambi, with a hefty price tag of £105,000 per patient per year – far higher than NHS England’s counter offer of £500m over 5 years across all patients. The number of disputes between the... Read More

The financial assumptions underpinning the Government’s plans to close the NHS’s 30-billion-pound funding gap by 2020/21 are unrealistic and are likely to lead to a decline in the quality of and access to healthcare for patients. Subsequently there is a growing risk that that some vital services will collapse.

Read More

The past 20 years have been trying ones for Santa Claus and the National Elf Service. The decision to split the purchasing of presents from their delivery was meant to improve efficiency, but he’s been having second thoughts…

Read More